FDA lifts partial clinical hold for some selinexor trialsMarch 31, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAggressive Lymphomas
Phase 2 study of daratumumab in NHL won’t proceedMarch 31, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
NCCN launches radiation therapy resourceMarch 29, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHematology NursingRelated Issues
CHMP recommends drug for relapsed/refractory cHLMarch 25, 2017Lymphoma & Plasma Cell DisordersPharmacyHodgkin LymphomaAggressive Lymphomas
Most blood cancer mutations due to DNA replication errorsMarch 24, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Preterm births more common in cancer survivorsMarch 24, 2017Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
ASCO reports progress, challenges in cancer careMarch 24, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHematology NursingPediatricsRelated Issues
New resource designed to help prevent CINVMarch 23, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHematology NursingPharmacyRelated Issues
FDA issues update on breast implant-associated ALCLMarch 22, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
AYAs struggle socially in early years after cancer diagnosisMarch 22, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsRelated Issues
Therapy can produce durable CRs in NHLMarch 17, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Veterans don’t have higher risk of leukemia, lymphomaMarch 15, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
FDA approves pembrolizumab to treat cHLMarch 15, 2017Lymphoma & Plasma Cell DisordersPharmacyHodgkin LymphomaAggressive Lymphomas
Family history impacts risk of second cancer after HLMarch 14, 2017Lymphoma & Plasma Cell DisordersHodgkin LymphomaAggressive Lymphomas
Selinexor trials placed on partial holdMarch 14, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyAMLNon-Hodgkin LymphomaAggressive Lymphomas
